Publication Online – June 2017
This guideline looks at four key questions regarding SBRT inch allenging clinical scenarios in early-stage NSCLC. It first offers recommendations on application of SBRT to operable patients. Next, the document
explores appropriate use of SBRT in tumors that are centrally located, large, multifocal or unbiopsied, as well as individual tailoring of SBRT in “high-risk” clinical scenarios. Finally, it addresses SBRT as salvage therapy after recurrence.
Read the executive summaryRead full guideline
Comparison of the Effectiveness of Radiofrequency Ablation with SBRT in Inoperable Stage I NSCLCASTRO’s SBRT Model Policy
Author SocietyAmerican Society for Radiation Oncology
EndorsementsAmerican Society of Clinical Oncology
The Royal Australian and New Zealand College of Radiologists
European Society for Radiotherapy and Oncology
ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical opinion. They are available to ASTRO members and the public for educational and informational purposes only. Commercial use of any content in this guideline without the prior written consent of ASTRO is strictly prohibited.